Skip to content

Clinical trials

Observational Breast Carcinoma In Situ trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Carcinoma In Situ Phase: Observational Country / region: United States Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20053
20061
20072
20081
20092
20161
20184
20211
20234
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting5
Terminated2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic5
Case Comprehensive Cancer Center2
City of Hope Medical Center2
University of Nebraska2
Duke University1
Medical College of Wisconsin1
Northwestern University1
Ohio State University Comprehensive Cancer Center1
PreludeDx1
Saint John's Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Carcinoma In Situ22
Breast Neoplasms17
Carcinoma, Intraductal, Noninfiltrating11
Carcinoma, Lobular3
Breast Neoplasms, Male2
Carcinoma, Ductal, Breast2
Anxiety Disorders1
Brain Neoplasms1
Hot Flashes1
Precancerous Conditions1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.